These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22319177)

  • 1. Incorporating molecular and functional context into the analysis and prioritization of human variants associated with cancer.
    Peterson TA; Nehrt NL; Park D; Kann MG
    J Am Med Inform Assoc; 2012; 19(2):275-83. PubMed ID: 22319177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
    Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
    Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein domain-level landscape of cancer-type-specific somatic mutations.
    Yang F; Petsalaki E; Rolland T; Hill DE; Vidal M; Roth FP
    PLoS Comput Biol; 2015 Mar; 11(3):e1004147. PubMed ID: 25794154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancer.
    Gauthier NP; Reznik E; Gao J; Sumer SO; Schultz N; Sander C; Miller ML
    Nucleic Acids Res; 2016 Jan; 44(D1):D986-91. PubMed ID: 26590264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein domain-centric approach for the comparative analysis of human and yeast phenotypically relevant mutations.
    Peterson TA; Park D; Kann MG
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S5. PubMed ID: 23819456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain landscapes of somatic mutations in cancer.
    Nehrt NL; Peterson TA; Park D; Kann MG
    BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence and structure signatures of cancer mutation hotspots in protein kinases.
    Dixit A; Yi L; Gowthaman R; Torkamani A; Schork NJ; Verkhivker GM
    PLoS One; 2009 Oct; 4(10):e7485. PubMed ID: 19834613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DMDM: domain mapping of disease mutations.
    Peterson TA; Adadey A; Santana-Cruz I; Sun Y; Winder A; Kann MG
    Bioinformatics; 2010 Oct; 26(19):2458-9. PubMed ID: 20685956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.
    Peterson TA; Gauran IIM; Park J; Park D; Kann MG
    PLoS Comput Biol; 2017 Apr; 13(4):e1005428. PubMed ID: 28426665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
    Mercatanti A; Lodovichi S; Cervelli T; Galli A
    FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spatial simulation approach to account for protein structure when identifying non-random somatic mutations.
    Ryslik GA; Cheng Y; Cheung KH; Bjornson RD; Zelterman D; Modis Y; Zhao H
    BMC Bioinformatics; 2014 Jul; 15():231. PubMed ID: 24990767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-Cancer Analysis of Mutation Hotspots in Protein Domains.
    Miller ML; Reznik E; Gauthier NP; Aksoy BA; Korkut A; Gao J; Ciriello G; Schultz N; Sander C
    Cell Syst; 2015 Sep; 1(3):197-209. PubMed ID: 27135912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes.
    Fujimoto A; Okada Y; Boroevich KA; Tsunoda T; Taniguchi H; Nakagawa H
    Sci Rep; 2016 May; 6():26483. PubMed ID: 27225414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
    Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
    Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-structure-guided discovery of functional mutations across 19 cancer types.
    Niu B; Scott AD; Sengupta S; Bailey MH; Batra P; Ning J; Wyczalkowski MA; Liang WW; Zhang Q; McLellan MD; Sun SQ; Tripathi P; Lou C; Ye K; Mashl RJ; Wallis J; Wendl MC; Chen F; Ding L
    Nat Genet; 2016 Aug; 48(8):827-37. PubMed ID: 27294619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferring the functional effects of mutation through clusters of mutations in homologous proteins.
    Yue P; Forrest WF; Kaminker JS; Lohr S; Zhang Z; Cavet G
    Hum Mutat; 2010 Mar; 31(3):264-71. PubMed ID: 20052764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
    Nono AD; Chen K; Liu X
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
    Bin Y; Wang X; Zhao L; Wen P; Xia J
    BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of the intersection of disease mutations with protein modifications.
    Simpson CM; Zhang B; Hornbeck PV; Gnad F
    BMC Med Genomics; 2019 Jul; 12(Suppl 6):109. PubMed ID: 31345222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.